Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Icard

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Advances in Nutrition (Bethesda, Md.)|February 2, 2021
Metabolic Strategies for Inhibiting Cancer DevelopmentPhilippe Icard, Mauro Loi, Zherui Wu, et al.
Cancers|January 26, 2020
Pre-Disease and Pre-Surgery BMI, Weight Loss and Sarcopenia Impact Survival of Resected Lung Cancer Independently of Tumor StagePhilippe Icard, Olivier Schussler, Mauro Loi, et al.
Carcinogenesis|February 10, 2010
Downregulation of Bcl-xL and Mcl-1 is sufficient to induce cell death in mesothelioma cells highly refractory to conventional chemotherapyEmilie Varin, Christophe Denoyelle, Emilie Brotin, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|December 20, 2021
Why may citrate sodium significantly increase the effectiveness of transarterial chemoembolization in hepatocellular carcinoma?Philippe Icard, Luca Simula, Zherui Wu, et al.
Bulletin Du Cancer|July 18, 2020
[Surgical management of resectable non-small cell lung cancer: Towards new paradigms]Mathilde Prieto, Antonio Bobbio, Ludovic Fournel, et al.
Cancer Letters|August 13, 2019
Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancerLudovic Fournel, Zherui Wu, Nicolas Stadler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 30, 2004
Risk of second primary cancer following differentiated thyroid cancerEmmanuelle Berthe, Michel Henry-Amar, Jean-Jacques Michels, et al.
Cancer Chemotherapy and Pharmacology|September 16, 2020
Nivolumab increases pulmonary artery pressure in patients treated for non-small cell lung cancerLudovic Fournel, Pascaline Boudou-Rouquette, Mathilde Prieto, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 19, 2022
The strategic roles of four enzymes in the interconnection between metabolism and oncogene activation in non-small cell lung cancer: Therapeutic implicationsPhilippe Icard, Luca Simula, Ludovic Fournel, et al.
Journal of Bioenergetics and Biomembranes|February 11, 2012
Experimental results using 3-bromopyruvate in mesothelioma: in vitro and in vivo studiesPhilippe Icard, Icard Philippe, Xiao-Dong Zhang, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Advances in Nutrition (Bethesda, Md.)|February 2, 2021
Metabolic Strategies for Inhibiting Cancer DevelopmentPhilippe Icard, Mauro Loi, Zherui Wu, et al.
Cancers|January 26, 2020
Pre-Disease and Pre-Surgery BMI, Weight Loss and Sarcopenia Impact Survival of Resected Lung Cancer Independently of Tumor StagePhilippe Icard, Olivier Schussler, Mauro Loi, et al.
Carcinogenesis|February 10, 2010
Downregulation of Bcl-xL and Mcl-1 is sufficient to induce cell death in mesothelioma cells highly refractory to conventional chemotherapyEmilie Varin, Christophe Denoyelle, Emilie Brotin, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|December 20, 2021
Why may citrate sodium significantly increase the effectiveness of transarterial chemoembolization in hepatocellular carcinoma?Philippe Icard, Luca Simula, Zherui Wu, et al.
Bulletin Du Cancer|July 18, 2020
[Surgical management of resectable non-small cell lung cancer: Towards new paradigms]Mathilde Prieto, Antonio Bobbio, Ludovic Fournel, et al.
Cancer Letters|August 13, 2019
Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancerLudovic Fournel, Zherui Wu, Nicolas Stadler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 30, 2004
Risk of second primary cancer following differentiated thyroid cancerEmmanuelle Berthe, Michel Henry-Amar, Jean-Jacques Michels, et al.
Cancer Chemotherapy and Pharmacology|September 16, 2020
Nivolumab increases pulmonary artery pressure in patients treated for non-small cell lung cancerLudovic Fournel, Pascaline Boudou-Rouquette, Mathilde Prieto, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 19, 2022
The strategic roles of four enzymes in the interconnection between metabolism and oncogene activation in non-small cell lung cancer: Therapeutic implicationsPhilippe Icard, Luca Simula, Ludovic Fournel, et al.
Journal of Bioenergetics and Biomembranes|February 11, 2012
Experimental results using 3-bromopyruvate in mesothelioma: in vitro and in vivo studiesPhilippe Icard, Icard Philippe, Xiao-Dong Zhang, et al.
Pageof 8